Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Otsuka Holdings Co ( (JP:4578) ) has issued an update.
Otsuka Holdings said its wholly owned unit Otsuka Pharmaceutical Factory America will inject USD 130 million into its newly formed U.S. subsidiary Otsuka Clinical Nutrition America, boosting the latter’s capital to USD 130 million and making it a specified subsidiary under Japanese disclosure rules. The move is aimed at strengthening Otsuka’s clinical nutrition and infusion-related manufacturing base in the United States, signaling a strategic push to expand its U.S. operations while the company expects no material impact on its consolidated earnings forecast in the near term.
The most recent analyst rating on (JP:4578) stock is a Buy with a Yen14100.00 price target. To see the full list of analyst forecasts on Otsuka Holdings Co stock, see the JP:4578 Stock Forecast page.
More about Otsuka Holdings Co
Otsuka Holdings Co., Ltd. is a Japan-based healthcare group with a primary focus on pharmaceuticals, medical devices, and related nutrition businesses. Through subsidiaries such as Otsuka Pharmaceutical Factory, it develops and manufactures infusion products and other clinical nutrition solutions, with an expanding market presence in the U.S. healthcare sector.
Average Trading Volume: 1,339,246
Technical Sentiment Signal: Buy
Current Market Cap: Yen5919.2B
Learn more about 4578 stock on TipRanks’ Stock Analysis page.